Skip to main content
. 2021 May 25;22(13):2325–2334. doi: 10.1002/cbic.202100110

Figure 8.

Figure 8

Comparison of optimised linalool and nerolidol product titres (A) and product ratio (B) obtained with the MVA pathway (NEB‐5α cells) and the IU pathway (NEB‐10β cells, 12.5 mM each isoprenol and prenol as substrates) using different bLinS variants.